Amgen profit tops expectations on Enbrel sales, tax credit
January 27, 2015 at 16:12 PM EST
Jan 27 (Reuters) - Amgen Inc on Tuesday reported higher-than-expected fourth-quarter profit, driven by strong sales of its blockbuster rheumatoid arthritis drug Enbrel, cost cutting and a tax credit.